It is an advanced GLP-1 and GIP receptor agonist, making it one of the most effective treatments for obesity, type 2 diabetes, and metabolic syndrome
These effects can lead to: Reduced dietary intake of B12-rich foods (meat, fish, dairy, eggs) Altered eating patterns with potential nutritional inadequacy Reduced nutritional intake if gastrointestinal symptoms are severe or prolonged Vitamin B12 deficiency can manifest with significant clinical consequences, including macrocytic anaemia, peripheral neuropathy, cognitive impairment, fatigue, and mood disturbances
Cloudiness, particles, discoloration, or changes in appearance signal potential degradation and indicate the vial should not be used, even if within the recommended timeline
Common causes of stalled progress include insufficient protein intake leading to metabolic slowdown, inadequate hydration affecting metabolism, missed or inconsistent injection timing, stress and sleep deprivation interfering with hormonal balance, and reaching a dose ceiling where higher doses no longer produce proportional benefits
Composition of Acetyl L-Carnitine Acetyl-L-carnitine, Capsule wall (cellulose (HPMC)), Bulking agent (microcrystalline cellulose (cellulose gel)), Anti-caking agent (magnesium stearate)
The generated ONOO - causes eNOS uncoupling, iNOS uncoupling, and BH 4 depletion [137]